Morbidity and mortality differences between populations, between ethnic groups and between individuals are not satisfactorily explained by the variation of risk factors. Differences in genetic susceptibility might be responsible for a part of the unexplained variation of coronary heart disease (CHD) rates.
H. N. NEUFELD, M.D., AND U. GOLDBOURT, M.A. SUMMARY Morbidity and mortality differences between populations, between ethnic groups and between individuals are not satisfactorily explained by the variation of risk factors. Differences in genetic susceptibility might be responsible for a part of the unexplained variation of coronary heart disease (CHD) rates.
Genetic factors are also significant in determining the level of risk factors in individuals. Ample evidence links genetic factors to the levels of serum cholesterol, blood pressure and diabetes. Marked sex differences in CHD mortality also indicate the role of heredity in the development of the disease. The male:female ratio varies widely between different countries, as well as between different ethnic groups. These variations are difficult to explain by variation in environmental and behavioral differences between males and females alone. The degree of atherosclerosis in males and females varies, depending on the anatomic location of the atherosclerosis.
Inherited disorders of metabolism and the variability of anatomic patterns provide additional indications of the role of genetics. The data accumulated in the Israeli Ischemic Heart Disease Study over 15 years reveal an ethnic variation of risk factors coupled with remarkably larger variation in disease rates. Patterns of incidence assessed in the national mortality data of the Israeli study and in histologic findings in the coronary arteries of infants from different ethnic groups are compatible with a hypothesis that ethnic and sex differences in early structural changes of the coronary arteries partly determine the susceptibility of the latter to the development of atherosclerosis.
In conclusion, findings from our studies and the review of the evidence from genetic epidemiologic investigations indicate a significant role of genetics in determining the degree, time course and severity of the atherosclerotic process and of the occurrence of symptomatic CHD. This important role of the genetic component is relevant to preventive strategies offered as tools for reducing the burden of CHD. Research into genetic determinants of both susceptibility to atherosclerosis or clinical manifestation of CHD and individual response to preventive measures should be encouraged. THE CONCEPT of a multifactorial etiology in coronary heart disease (CHD) is well established, based on evidence from postmortem studies, animal experiments and long-term epidemiologic observations. These studies have provided us with a whole range of risk factors found to precede the onset of clinical heart disease. Although there is a consensus regarding causation for some of them, their combined action still fail's to explain fully the variation in CHD incidence and mortality among different population groups. The best prediction achieved is usually 50% of cases in the top 20% of computed risk. 24 In several studies, CHD rates of specific ethnic groups were found to differ from other groups to an extent that could not be ex-the Lapps of the Finnmark County in Norway,7 the Yemenite-born Israelis,8 East and West Finns,9 and residents of Puerto Rico compared with those of Hawaii and mainland U.S.A. 10 One of the major issues that has arisen in the attempt to explain these variations is the relative role of heredity vs environment "nature vs nurture." The controversy over the roles of these two factors, and our inability to account in full for the range of incidence rates, is reflected in the substantial genetic components elucidated for diabetes mellitus," hypertension'2 and low-density lipoprotein (LDL) cholesterol'3 and highdensity lipoprotein (HDL) cholesterol'4 levels in the blood. In addition to the genetic contribution to risk factor variation, the existence of a genetic predisposition in CHD is clearly expressed in differences in the anatomic and histologic distribution patterns of the coronary arteries and in inherited disorders of metabolism. Genetic factors may have already marked some individuals in embryo for early changes in the coronary arteries, and others for late onset. 943 NO 5 1983 The complexities of CHD pose extremely difficult problems for analysis of the genetic component. Innumerable physiologic and biochemical variables and environmental agents intervene before CHD reaches the critical period when its clinical manifestations are expressed in rapidly increasing rates.
The early stage in the history of CHD is the incubation period, during which fibrous plaques have not yet appeared. Later in the asymptomatic period, coronary arteriosclerosis of varying degrees develops, and may exist for years, sometimes decades, before the disease is manifest clinically. It may produce myocardial infarction (MI) and sudden death within seconds or minutes. Symptomatic CHD can also occur in a less common group of patients with normal vessels, in whom a completely different mechanism is at work.
In the search for risk factors, we use clinical disease manifestations as end points: angina pectoris, MI and sudden death. Defining these end pointseven MI (the clinically most obvious one) -produces obscurities and inconsistencies. On the other hand, many people live for years with severe coronary arteriosclerosis and do not develop thrombosis or infarction. The condition precipitating the terminal occlusive event may be a factorgenetic, environmental or bothpossibly unrelated to the decade-long process of an atherogenesis. No one has specifically identified such a factor.
If MI can occur without a permanent obstructive lesion in the coronary arteries, it follows that an MI in the presence of a permanent stenosis in a coronary artery is not necessarily caused by narrowing alone. A question that has occupied investigators in recent years is the role of spasm in the occlusive event. Little knowledge is available with respect to genetic or environmental factors predicting coronary artery spasm.'5 It has been shown, for instance, that sudden death can occur in people with normal coronary arteries.'6 If sudden death strikes without demonstrable coronary artery lesions, one must be cautious in treating it as a possible end point of the atherosclerotic process. Among the factors that may affect the risk of sudden death are genetic differences in the conduction system of the heart, the distribution pattern of the coronary arterial tree, myocardial metabolism, coronary artery spasm and platelet aggregation.
In recent years, the genetics of hyperlipidemia, diabetes and hypertension have gained increasing attention. [11] [12] [13] [14] 17 While the research is difficult enough given the paucity of methods for identifying polygenic effects, the studies also miss the genetic determinants of the arterial wall's reaction to different risk factor levels in different individuals. The genetically controlled characteristics of the arterial wall have not received sufficient attention, despite their high likelihood of explaining variability in the susceptibility of the arterial wall response to hyperlipidemia and other risk factors. II Since the early 1960s, part of our research activities have been devoted to the role of genetics in CHD. We studied the morphology and structure of coronary arteries in children of different ethnic groups'9 and in adults up to the age of 40 years,20 and at the same time carried out prospective epidemiologic surveys in Israel, with particular emphasis on ethnic group differences. 21 We integrate here relevant findings related to the following aspects of genetics and CHD: the male:female incidence and mortality ratios, the unexplained variability of risk factors, CHD in children, variability in CHD patterns, inherited disorders of metabolism, and CHD incidence differences among ethnic groups, all of which cannot be accounted for by "risk profile" variation.
Sex Differences in Coronary Heart Disease
While both atherosclerosis of the coronary arteries22 and incidence of CHD23 are markedly higher in males, the sex difference is greatest in CHD among Western white persons, and is remarkably lower in blacks, Jews of Mideastern descent, and several other ethnic groups. Differences in known risk factors fail to explain satisfactorily the male sex predominance in either atherosclerosis or CHD incidence.24 For example, in Finland, where high cholesterol levels characterize both sexes, CHD disease reaches record dimensions only in males (whose mortality rate at age 40-70 years is nearly five times that of the females). There is little or no sex difference in any racial or ethnic group in either lesions or clinical disease related to cerebral arteries, the aorta or peripheral arteries. 24 The predisposition of the white male to develop advanced coronary atherosclerosis and CHD without a similar excess of aortic atherosclerosis suggests that the coronary arteries of white males of European origin are peculiarly susceptible to atherogenesis. Even if the white male has high levels of established risk factors, they do not explain the selectivity of one arterial system.1 '8 24 The severe coronary artery changes of marked intimal proliferation described in two congenital anomalies -coarctation of the aorta25 and supravalvular aortic stenosis26 are also more frequent in males. Supravalvular aortic stenosis occurs also as a familial syndrome.
A finding that seems to mystify the issue further with respect to male sex as a risk factor is the great diversity of male:female ratios observed in CHD mortality rates in different countries and in different ethnic groups within one country. In Finland, the male:female mortality ratio was always the highest. In the U.S.A., the ratio in 1940 was 1.81 in whites, compared with only 1.31 in nonwhites;27 in 1963, at the peak of the "coronary epidemic, " the respective ratios increased to 2.50 and 1.53; and by 1975, despite a major decline of the rates, the sex ratios increased slightly, to 2.70 and 1.63. Whatever environmental interaction and selective trends of case fatality contributed to sex-specific incidence, the profound excess of male:female ratio in whites compared with blacks persisted. Recent World Health Organization data28 show that while in Finland the 1975 ischemic heart disease mortality ratio at ages 40-70 years was as high as 4.74, in Bulgaria it was as low as 2.15, and in Israel it was 1.92, the lowest known ratio. Table 1 shows the diversity of male:female ratios.
The widely varying sex ratios are very difficult to interpret on environmental grounds, as men and women apparently share many common habits, including diet. The outstanding dissimilarities between sex mortality ratios seems to enhance the role of heredity in determining who is at risk for CHD. The sex differences observed in morphologic studies described later in this article might indicate how early such dissimilarities originate.
Genetics in the Variability of Coronary Risk Factors Risk factors for CHD are determined to a significant degree by heredity, but the nature and degree of their inheritance is not defined. The familial aggregation of coronary risk factors is explained by some as mostly reflecting common environment, notably common eating habits, but considerable epidemiologic evidence suggests that the genetic component is predominant in the variability of these factors.
One of the hereditary factors in CHD seems to be the genetic control of lipid and lipoprotein levels.'3 In addition to the rarely encountered inherited familial hypercholesterolemia, some investigators contend that the variation of low-density lipoprotein (LDL) cholesterol is also largely determined by heredity. This suggestion is supported by the failure to explain the cholesterol variation in large epidemiologic studies.29 There is an ongoing controversy over the role of dietary habits in cholesterol levels. According to Liu and co-workers,30 the failure to estimate dietary habits of persons due to a large component of intraindividual variance could mask a correlation between dietary intake and serum cholesterol. For some, this removes the difficulty of zero correlations between diet and cholesterol. Others point to the variation of cholesterol among individuals in a society as indicating the important role played by genetics. The results of the Seven Countries study3' have led to the hypothesis that environmental factors are mainly responsible for differences between population means while genetic variation is the major determinant of the variation within populations.
Sing and co-workers29 analyzed familial data in an effort to separate the genetic effect from environmental components. Comparing correlations between spouses and relatives living in different households, and using several alternative models, they estimate that the shared household accounts for no more than 20% of the cholesterol variability. The results are based on the Tecumseh study. Table 2 presents estimates of heritability in serum cholesterol for several studies. The figures given are the estimated fraction of the correlation between full siblings living together, which is assigned to shared genes. These findings show a remarkable homogeneity in explaining full-sibling correlation, and imply that a general etiologic basis for familial aggregation of cholesterol levels might exist independent of lifestyle difference of the population studies. Sing et al.29 reviewed parent-child correlations by sex combinations and found them all to average around 0.25. They contend that hypercholesterolemics appear to be genetically predisposed to resist intervention by dietary or other means aimed at reducing the cholesterol level. When calculation was made of the potential alteration of CHD risk based on the previously mentioned estimates for full-sibling correlation assigned to polygenes, attempting to remove environmental variability by intervening on the entire population was no more effective than intervening only on individuals in the upper cholesterol percentile.,3 32 Garrison et al.33 analyzed cholesterol levels in firstdegree relatives and in spouse pairs. They found that, on adjustment for confounders, the correlation disappeared only for the spouse pairs. This fact points towards intrauterine influence on both LDL and highdensity lipoprotein (HDL) concentrations as an important source of population variance, be it genetic or acquired in pregnancy. The findings summarized here provide considerable evidence for genetic components in the variation of serum cholesterol.
HDL Cholesterol
Garrison's analysis33 also represents one of the few data sets on possible genetic determination of HDL. In the Israeli Ischemic Heart Disease Study, an analysis of the multiple correlation between HDL cholesterol levels and 15 variables yielded a correlation coefficient of only 0.35, so that R2 (percent of variance explained by the variables included in the regression) was 0.12 (table 3) .
There are notable racial and sex differences in HDL In 1963, McKusick38 mentioned the "pernicious nature of hypertension in the American black. " He noted that although genetic factors were strongly implicated, the details of the genetics of hypertension were a matter of dispute.
Platt39 was convinced that hypertension was a hereditary disease. He based his opinion mostly on findings of malignant hypertension in monozygotic twins who lived apart for many years, in contrast to considerable difference in dizyotic twins. He assumed a major role for a single additive gene. Pickering40 stated that a tendency for higher pressure at all ages, rather than the rate of rise, is inherited: He presumed the latter to represent the effects of environment and concluded that environment is more important as a cause of hypertension. Low correlation of blood pressure between spouses, found in Tecumseh, indirectly supports a more than negligible role for heredity in determining blood pressure levels. This was also the case in Miall and Oldham's data on Welshmen.4'
Yamori42 used the experimental model of spontaneously hypertensive rats to establish stroke-prone spontaneously hypertensive rats and arteriolipidosis in rats. He interpreted his findings to "clearly indicate that gene-environment interaction is important in the pathogenesis of hypertension, stroke and atherosclerosis'" and that these diseases are "predictable by detecting genetic predispositions." Feinleib et al. 43 considered the relative contributions of environmental and genetic factors to blood pressure, and they estimated that about 30% of the total variability in blood pressure among individuals can be ascribed to the dominance of genes acting pairwise. Biron and Mongeau"4 found correlations of 0.28-0.37 between blood pressure measurements of biologic first-degree relatives, but only 0.03-0.09 between parents and adopted children.
In an examination of blood pressure aggregation in families, Havlik et al.45 evaluated measurements of GENETIC ASPECTS OF CHDfNeufeld and Goldbourt Framingham offspring compared with parents' measurements taken 25 years previously. Despite adjustment for many blood pressure correlates, both paternal and maternal blood pressure remained independent predictors of blood pressure in offspring. Conversely, spouse correlation vanished after a similar adjustment.
A recent examination of the Collaborative Perinatal Project by Havlik et al.Y indicated a significant genetic variability of diastolic blood pressure for 7-year-old twins, with heritability estimates of 0.5 1 in blacks and 0.71 in whites (table 5) . Annest et al. 47 used the design of the Montreal Adoption Survey which allowed for a genetic analysis of the familial aggregation of blood pressures. They state that shared environment explains larger fractions of the parent-natural child and the full-sib correlations for diastolic than for systolic blood pressure. However, the fraction of sex-and age-adjusted phenotypic variability attributable to genetic differences was estimated at 0.34 ± 0.08 (systolic) and 0.03 + 0.08 (diastolic) by maximum likelihood estimation procedure of the household data. In Japanese-American families in Hawaii, Morton et al.48 estimated these fractions were 0.25 (systolic) and 0.18 (diastolic). In the analysis by Ward et al. 49 of Polynesian families in the Tokelau Islands, the respective estimates were 0.28 and 0.25. These estimates tend to be consistent among studies. While the evolutionary forces stabilizing the genetic variability of blood pressure are not understood, the body of accumulated data points to the importance of genetic variance in the early control of blood pressure levels.46
Diabetes
The prevalence of diabetes ranges from less than 1% (Alaskan Eskimos, Pacific Melanesians) to 40% (Pima Indians). Genetic factors appear to be prominent in explaining the variation of diabetes. Conversely, apart from obesity, very little contribution of other risk factors has been ascertained.50 Most of the Indian tribes in which diabetes is now rife are quite small in numbers, a fact consistent with the possibility that inbreeding may have led to an increase in the frequency of diabetogenic genes. Diabetes is extremely prevalent, however, only in fat tribes, and most notably among the Pima Indians.5" A popular theory is Neel's "thrifty genotype,'"52 whereby a trait developing by selection may be advantageous during starvation and become harmful under an unlimited caloric supply. This theory is a unique explanation for the excess incidence of diabetes identified in our data on Oriental communities in Israel, among whom diabetes was little known in their country of origin.53 These ethnic groups were likely to have emerged rapidly from deprivation to feast, and may have been subjected to the effect of such a phenomenon, if true. Jackson,54 who surveyed the differences between White Bantu and Indian South Africans, concluded that ethnic differences involving prevalence, variety and complications of diabetes are unlikely to be entirely explained by environmental factors, and concluded that "fundamental racial, presumably genetic, differences appear to be ineluctable." In a review of HLA studies in diabetes mellitus, Nerup5s concluded that HLA-B3 is associated with insulin-dependent diabetes (IDD) in all Caucasian populations, irrespective of age of onset. In the Japanese, IDD occurs in association with BW22. A gene-dose effect exists, and there are apparently one or more IDD-associated genes within the HLA region. Environmental stimuli are required as triggering mechanisms for IDD to develop on the background of genetic susceptibility.
Genetics and Multiple Risk Factors
A recent study by Snowden et al. 56 presented concordance of CHD among siblings of the Framingham Heart Study. The risk of CHD (other than angina) in both brothers of a pair is more than 1.5 times as great as expected. The incidence of MI in the older brother was significantly related to the MI experience of the younger brother, even after the effects of total cholesterol, systolic blood pressure and cigarette smoking were controlled in a multivariate analysis. The adjusted odds ratio associated with MI experience in the older brother was 1.51 for MI and 1.55 for CHD death, respectively, in the younger one. The authors conclude that familial aggregation for CHD may result from predisposition to disease, possibly genetic, that is not mediated through known risk factors.
Inherited Disorders of Metabolism and Syndromes
Coronary arterial involvement is present in many inherited disorders of metabolism and in various syndromes. This coronary involvement is often severe and may be responsible for the main clinical presentation of the disease. In these metabolic diseases, a genetically determined abnormality of enzyme function results in either an absence or a low concentration of a specific enzyme. As a result, partly processed metabolites accumulate in various tissues, including the coronary arteries. Coronary involvement was found in the following inherited disorders of metabolism5762: (1) mu-copolysaccharidosis
Hurler's and Hunter's syndromes; (2) disorders of protein and amino acid metabolism primary hyperoxoluria, alkaptonuria and homocystinuria; and (3) disorders of lipid metabolism -Fabry's disease, Sandhoff's disease, GM1 gangliosiodosis, hyperlipoproteinemia and Tangier's disease.
In the progeria syndrome,63 premature aging results in severe arteriosclerosis in childhood. Affected children present with angina pectoris, MI and congestive heart failure.
Anatomic Pattern Variability
Variations in the pattern of origin and distribution of the coronary arteries are well known in the general population. Some of these changes, appearing to be genetically determined, may be related to the development of coronary atherosclerosis.
Pepler et al./ demonstrated what they called a third primary division in the left coronary artery, which was significantly more prominent in Bantu (in whom coronary atherosclerosis is rare) compared with Europeans. Sidd et al.65 demonstrated angiocardiographically similar coronary vascular patterns in four brothers. Our own experience in three pairs of siblings revealed not only identical anatomic patterns of coronary arteries, but almost identical pathologic findings as well. Displacement of the coronary ostium may lead to the production of aggravation of CHD. An abnormally high origin of the coronary artery may impair coronary blood flow by leading to a decreased filling pressure due to turbulent flow and skimming effects. A congenitally hypoplastic coronary artery is more susceptible to the consequences of atherosclerosis. Gazetopoulos et al.A6 reported that a long main left coronary artery exerts some protective effect against the development of atherosclerosis in its branches.
Ethnic Differences in CHD Incidence and Mortality
Large differences in CHD mortality have been observed in European and other Western countries. These differences were evident within countries and even within geographic regions between ethnic groups. As noted in the preceding discussion, these differences were often dissimilar for men and women.
Several incidence studies have shown that the ethnic mortality differences are not merely a reflection of case fatality. In Evans County, Georgia, the age-adjusted 7year incidence among white males was 3.5 times greater than that among blacks, while among women the racial differences was negligible. Information regarding risk factors was available at the beginning of the study. Kleinbaum et al.5 found that blacks responded to a given risk profile much more mildly than did whites. The relative contribution to the risk was similar, but the actual incidence of clinical CHD was only one-fourth of that expected (table 6) . The difference should lie with an increased susceptibility of white men. One possibility is a genetically determined susceptibility.
In Norway, Lapps, Norsemen and Finns have been compared in terms of risk factors and prevalence of CHD among first-degree relatives.7 A marked predominance was found in relatives of Finns compared with Lapps, despite great similarity in mean cholesterol and mean diastolic blood pressure and only slightly and nonsignificant lower levels for systolic blood pressure and cigarette smoking for the Lapps (table 7) . Although these were not incidence data, they strongly suggested that ethnicity played a key role in determnining susceptibility to CHD. The authors concluded that "most of the risk determined by having one or more first-degree relatives with MI is independent of the common coronary risk factors." Whether the social structure and other factors not expressed in blood pressure and serum cholesterol, or genetic factors, account for the differences between the ethnic groups in Finmark County remains an open question.
The Israeli Ischemic Heart Disease study, 3' 21, 67, 68 initiated in 1961, involved three extensive examinations of 10,000 male civil servants and municipal employees, 8600 of whom were immigrants. Information is available on risk factors, 5-year incidence of CHD and diabetes, and 7-year mortality. The sampling was stratified using varying sampling ratios within six areas of birth: Eastern Europe, Central Europe, the Balkan Countries, Israel, the Middle East and North Africa. While these regions are geographically determined, it is common knowledge that Jews born in Germany have many morphologic and ethnic properties which distinguish them from those born in Yemen or Algeria, for example. A detailed analysis of genetic data on Jewish population including heterogeneity indices and distance measures has been published recently.69 Table 8 presents a comparison of mean levels for some risk factors, showing differences only for smoking and total cholesterol. Logistic risk functions predicting the occurrence of MI in 5 years have been calculated from the pooled Israeli study data.3 70 The discriminating power is comparable to those achieved Abbreviations: SBP = systolic blood pressure; DBP = diastolic blood pressure; W/H2 = index); MI = myocardial infarction. in the Framingham study4 and similar prospective studies. We applied these "average" predictive functions to every individual, thus calculating individual probabilities of developing a clinical manifestation of CHD. We subsequently summed up the probabilities in each of the specific sampling areas. Table 9 illustrates clearly that the risk for developing either MI or definite angina pectoris varies among the six groups beyond the degree which a multiple adjustment for risk factors can explain. Specifically, men born in the Middle East clearly have unaccountable attributes that protect them against the onset of clinical coronary disease, as the sum of their 5-year risks remains much lower than that of the European born after risk factor adjustment.
Within the Middle Eastern groups, probably the genetically more heterogenous one,69 the Jews born in Yemen8 are of special interest. They lived in isolation for many years, and intermarriage with non-Jews was apparently very rare. Table 10 shows the adjusted rela-weight/height2 (Quetelet tive risk for developing MI in individual countries of birth in a manner similar to table 9. The estimated risk for Yemenite born Jews is clearly below that of all others. The incidence difference seems to go beyond risk profile dissimilarity.
In viewing the low incidence of CHD in the Yemenite groups, we should consider the length of stay in Israel as a potentially important factor that may be reflected in variables other than the ones adjusted for in the analysis. This group has, in fact, been in the country for an average of 30 years, 83% having emigrated from Yemen before the establishment of the State of Israel in 1948. Any protective environmental effect therefore would appear to be one active in childhood.
Eighty percent of the Yemenite-born men were reexamined 10 years later. Twenty-three new cases of definite CHD were found, constituting the first prospective data available for identification of variables preceding CHD in Yemenite-born Israelis. Twelve of the cases were fatal. Abbreviations: HDL = high-density lipoprotein; SBP = systolic blood pressure; DBP = diastolic blood pressure. The findings on the Yemenite group turned up factors predicting CHD that were generally in agreement with those identified for Western populations. Table  11 shows initial elevated levels for overweight, systolic and diastolic blood pressure, and prevalence of diabetes. HDL levels were not significantly lower for men who developed clinical CHD over 15 years, while total cholesterol had been elevated only in the fatal cases. The assumption of a "Western-type" risk function for the Yemenite-born appears to have been appropriate in assessing their adjusted relative risk. Thus, this is a group in which the clinical response to a given level of risk factors is reduced compared with that of Jews born in other countries.
The incidence findings for the Yemenite-born Israelis in relation to other ethnic groups are analogous to those from the Evans County study and to findings by Gordon et al.10 in a tripartite study: the incidence of CHD in males from Honolulu and Puerto Rico was half that expected when calculated on the basis of the Framingham study risk function ( fig. 1 ). The persistence tNumber in parentheses denotes less than 10 expected incidence cases.
Abbreviations: MI = myocardial infarction; AP = angina pectons.
of diversity of incidence rates between ethnic groups after risk factor adjustment poses a dilemma. What portion of the diversity is genetically determined, and what might arise indirectly from a genetic basis (remembering that risk factor variability also has a pronounced genetic basis)? The following discussion of ethnic morphologic findings is relevant.
Ethnic and Sex Differences in Early Structural Changes of the Coronary Arteries
Could marked differences in CHD mortality between Yemenites and the rest of the Israeli population be related to differences in structural changes in coronary arteries?
Several years ago we examined 211 infants and children up to 10 years of age.71 Table 12 gives the distribution of age in the three ethnic groups: Ashkenazi Jews (Jews of European origin), Bedouins and Yemenite Jews. We used only specimens of children who died of causes other than cardiac ones. Figure 2 shows the marked differences in the structure of the coronary arteries as age progresses: note the pronounced change in the Ashkenazi Jew compared with the two other groups. Two investigators independently measured the mean values of the intimal and internal muscular layers in these same three ethnic groups. Table 13 demonstrates definite statistically significant differences in the males of the Ashkenazi and the two other ethnic groups. The same measurements in females yielded practically no differences ( fig. 3) .
These data complement a set of findings indicating that CHD incidence late in life may depend to a considerable extent on genetically determined ethnic and sex variations in structural changes in the coronary arteries. First, coronary arterial changes were more marked in Ashkenazi males than in Ashkenazi females, Yemenite males or Yemenite females. Second, risk factor-adjusted CHD incidence remains considerably lower in Yemenite-born immigrants who have lived in Israel for a long time. This assessment is justified on the basis of having verified a Western-type coronary profile for the Yemenite-born Israelis. Third, Israeli mortality statistics show a far greater CHD death rate for Europeanand Iraqi-born Israeli Jews tCHD incidence was 7% in nonsmokers, 5.9%, 8.3% and 18.4% in men smoking 1-10, 11-20 or 21 + cigarettes per day, respectively. The association becomes significant only after multivariate adjustment. For 31 men with unknown history of CHD during the follow-up period, mean values at baseline were identical or very close to those of the noncases.
Abbreviations: SBP = systolic blood pressure; DBP = diastolic blood pressure; CHD = coronary heart disease. ethnic groups parallel the morphologic findings in infants. A tentative explanation for these ethnic differences in the sex-specific mortality ratio could be genetically determined morphologic changes in their coronary arteries. Similar changes in the musculoelastic layer and intimal thickening have been described by Dock,73 Schor-nagel74 and Pesonen et al.,75 who also found more prominent changes in males than in females. The similarity of our findings to those of Pesonen et al.75 iS of particular interest: They demonstrated that coronary artery thickening in Eastern Finnish children is markedly more pronounced than in Western Finns. The differences parallel the notorious East-West gap of CHD incidence and mortality. A different genetic origin has been postulated for the people residing in the East who, it is speculated, arrived through the Ladoga Lake and are of Mongolian descent, while the Western people were predominantly of Scandinavian-Saxon origin.
Early-life ethnic differences in the degree of collagen formation could be related to nutritional deficiency or other external factors affecting collagen synthesis. Such an explanation, however, is not appropriate for sex differences within ethnic groups. We assume, therefore, that intrinsic factors are mainly responsible for differences in collagen tissue formation in the coronary arteries of males and females as well as in differ-ent ethnic groups. Further studies of this early-life variation undertaken in groups known to differ in the incidence of CHD would assist in establishing how much of the clinically manifested atherosclerotic disease is dictated by inherited pre-arteriosclerotic factors. 
